nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCB1—peripheral nervous system neoplasm	0.123	1	CbGaD
Paclitaxel—TUBB2B—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB8—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB6—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB2A—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB3—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB4A—Vincristine—peripheral nervous system neoplasm	0.0374	0.0604	CbGbCtD
Paclitaxel—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.0313	0.0506	CbGbCtD
Paclitaxel—TUBB1—Vincristine—peripheral nervous system neoplasm	0.0313	0.0506	CbGbCtD
Paclitaxel—TUBB—Vincristine—peripheral nervous system neoplasm	0.0313	0.0506	CbGbCtD
Paclitaxel—ABCC10—Vincristine—peripheral nervous system neoplasm	0.0239	0.0386	CbGbCtD
Paclitaxel—ABCC10—Etoposide—peripheral nervous system neoplasm	0.0219	0.0354	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.015	0.0242	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.0149	0.0241	CbGbCtD
Paclitaxel—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0145	0.0234	CbGbCtD
Paclitaxel—ABCB11—Vincristine—peripheral nervous system neoplasm	0.013	0.021	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0108	0.0175	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.01	0.0162	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.00993	0.0161	CbGbCtD
Paclitaxel—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.00993	0.0161	CbGbCtD
Paclitaxel—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00922	0.0149	CbGbCtD
Paclitaxel—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00845	0.0137	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.00811	0.0131	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.00811	0.0131	CbGbCtD
Paclitaxel—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00745	0.012	CbGbCtD
Paclitaxel—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.00716	0.0116	CbGbCtD
Paclitaxel—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00683	0.011	CbGbCtD
Paclitaxel—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00637	0.0103	CbGbCtD
Paclitaxel—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00626	0.0101	CbGbCtD
Paclitaxel—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00617	0.00998	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00576	0.00932	CbGbCtD
Paclitaxel—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00576	0.00931	CbGbCtD
Paclitaxel—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00566	0.00915	CbGbCtD
Paclitaxel—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00521	0.00843	CbGbCtD
Paclitaxel—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00521	0.00843	CbGbCtD
Paclitaxel—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00499	0.00808	CbGbCtD
Paclitaxel—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00456	0.00737	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00456	0.00737	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00427	0.0069	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00386	0.00624	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00361	0.00584	CbGbCtD
Paclitaxel—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00342	0.00553	CbGbCtD
Paclitaxel—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00313	0.00507	CbGbCtD
Paclitaxel—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00312	0.00505	CbGbCtD
Paclitaxel—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00301	0.00487	CbGbCtD
Paclitaxel—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0029	0.0047	CbGbCtD
Paclitaxel—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00223	0.0036	CbGbCtD
Paclitaxel—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00214	0.00346	CbGbCtD
Paclitaxel—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00208	0.00336	CbGbCtD
Paclitaxel—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00204	0.0033	CbGbCtD
Paclitaxel—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00225	CbGbCtD
Paclitaxel—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00133	0.00216	CbGbCtD
Paclitaxel—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00122	0.00198	CbGbCtD
Paclitaxel—MAP2—nerve—peripheral nervous system neoplasm	0.00105	0.0777	CbGeAlD
Paclitaxel—MAP2—ganglion—peripheral nervous system neoplasm	0.00104	0.0767	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000833	0.00135	CbGbCtD
Paclitaxel—MAPT—trigeminal ganglion—peripheral nervous system neoplasm	0.000822	0.0609	CbGeAlD
Paclitaxel—MAP4—trigeminal ganglion—peripheral nervous system neoplasm	0.000646	0.0479	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—peripheral nervous system neoplasm	0.000635	0.553	CrCbGaD
Paclitaxel—MAP4—brainstem—peripheral nervous system neoplasm	0.000572	0.0423	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—peripheral nervous system neoplasm	0.000513	0.447	CrCbGaD
Paclitaxel—MAP2—trigeminal ganglion—peripheral nervous system neoplasm	0.000509	0.0377	CbGeAlD
Paclitaxel—MAP2—parotid gland—peripheral nervous system neoplasm	0.00048	0.0355	CbGeAlD
Paclitaxel—BCL2—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000472	0.118	CbGdCrCtD
Paclitaxel—MAP2—brainstem—peripheral nervous system neoplasm	0.00045	0.0333	CbGeAlD
Paclitaxel—BCL2—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.0986	CbGdCrCtD
Paclitaxel—BCL2—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.0986	CbGdCrCtD
Paclitaxel—BCL2—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000394	0.0986	CbGdCrCtD
Paclitaxel—BCL2—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000394	0.0986	CbGdCrCtD
Paclitaxel—TUBB4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000393	0.0291	CbGeAlD
Paclitaxel—TUBB2B—trigeminal ganglion—peripheral nervous system neoplasm	0.00038	0.0281	CbGeAlD
Paclitaxel—TUBB—trigeminal ganglion—peripheral nervous system neoplasm	0.00036	0.0266	CbGeAlD
Paclitaxel—MAPT—cerebellum—peripheral nervous system neoplasm	0.000358	0.0266	CbGeAlD
Paclitaxel—TUBB2B—parotid gland—peripheral nervous system neoplasm	0.000358	0.0265	CbGeAlD
Paclitaxel—TUBB2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000358	0.0265	CbGeAlD
Paclitaxel—TUBB6—trigeminal ganglion—peripheral nervous system neoplasm	0.000353	0.0261	CbGeAlD
Paclitaxel—TUBB4A—brainstem—peripheral nervous system neoplasm	0.000348	0.0258	CbGeAlD
Paclitaxel—TUBB—parotid gland—peripheral nervous system neoplasm	0.000339	0.0251	CbGeAlD
Paclitaxel—TUBB2A—parotid gland—peripheral nervous system neoplasm	0.000337	0.025	CbGeAlD
Paclitaxel—TUBB6—parotid gland—peripheral nervous system neoplasm	0.000333	0.0246	CbGeAlD
Paclitaxel—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	0.000309	0.0229	CbGeAlD
Paclitaxel—TUBB4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000307	0.0227	CbGeAlD
Paclitaxel—BCL2—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.0747	CbGdCrCtD
Paclitaxel—BCL2—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.0747	CbGdCrCtD
Paclitaxel—ABCC10—parotid gland—peripheral nervous system neoplasm	0.000291	0.0216	CbGeAlD
Paclitaxel—TUBB4B—parotid gland—peripheral nervous system neoplasm	0.000289	0.0214	CbGeAlD
Paclitaxel—TUBB3—cerebellum—peripheral nervous system neoplasm	0.000282	0.0209	CbGeAlD
Paclitaxel—MAP4—cerebellum—peripheral nervous system neoplasm	0.000282	0.0209	CbGeAlD
Paclitaxel—MAP2—cerebellum—peripheral nervous system neoplasm	0.000222	0.0164	CbGeAlD
Paclitaxel—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000206	0.0153	CbGeAlD
Paclitaxel—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000204	0.0511	CbGdCrCtD
Paclitaxel—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000204	0.0511	CbGdCrCtD
Paclitaxel—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000181	0.0134	CbGeAlD
Paclitaxel—TUBB4A—cerebellum—peripheral nervous system neoplasm	0.000172	0.0127	CbGeAlD
Paclitaxel—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000171	0.0126	CbGeAlD
Paclitaxel—TUBB2B—cerebellum—peripheral nervous system neoplasm	0.000166	0.0123	CbGeAlD
Paclitaxel—TUBB—cerebellum—peripheral nervous system neoplasm	0.000157	0.0116	CbGeAlD
Paclitaxel—TUBB2A—cerebellum—peripheral nervous system neoplasm	0.000156	0.0116	CbGeAlD
Paclitaxel—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.0387	CbGdCrCtD
Paclitaxel—TUBB6—cerebellum—peripheral nervous system neoplasm	0.000154	0.0114	CbGeAlD
Paclitaxel—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000143	0.0357	CbGdCrCtD
Paclitaxel—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.0357	CbGdCrCtD
Paclitaxel—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.0357	CbGdCrCtD
Paclitaxel—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000143	0.0357	CbGdCrCtD
Paclitaxel—ABCC10—cerebellum—peripheral nervous system neoplasm	0.000135	0.00998	CbGeAlD
Paclitaxel—TUBB4B—cerebellum—peripheral nervous system neoplasm	0.000134	0.00991	CbGeAlD
Paclitaxel—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.0271	CbGdCrCtD
Paclitaxel—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.0271	CbGdCrCtD
Paclitaxel—CYP1B1—cerebellum—peripheral nervous system neoplasm	0.000106	0.00785	CbGeAlD
Paclitaxel—ABCC1—cerebellum—peripheral nervous system neoplasm	9.53e-05	0.00706	CbGeAlD
Paclitaxel—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	8.92e-05	0.00661	CbGeAlD
Paclitaxel—ABCG2—cerebellum—peripheral nervous system neoplasm	7.89e-05	0.00584	CbGeAlD
Paclitaxel—ABCB1—cerebellum—peripheral nervous system neoplasm	3.89e-05	0.00288	CbGeAlD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.89e-05	0.000682	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	3.85e-05	0.000675	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.84e-05	0.000673	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	3.8e-05	0.000666	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—BIRC5—peripheral nervous system neoplasm	3.79e-05	0.000665	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.79e-05	0.000665	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.78e-05	0.000663	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	3.78e-05	0.000663	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.77e-05	0.000661	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—peripheral nervous system neoplasm	3.74e-05	0.000655	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.72e-05	0.000652	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.7e-05	0.00065	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	3.67e-05	0.000643	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.64e-05	0.000638	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.6e-05	0.000632	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.54e-05	0.000622	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	3.51e-05	0.000617	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD34—peripheral nervous system neoplasm	3.47e-05	0.000609	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.43e-05	0.000601	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.42e-05	0.000599	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PPP3R1—peripheral nervous system neoplasm	3.34e-05	0.000586	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.33e-05	0.000584	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000579	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	3.28e-05	0.000575	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.26e-05	0.000573	CbGpPWpGaD
Paclitaxel—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000178	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000178	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	3.24e-05	0.000178	CcSEcCtD
Paclitaxel—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	3.24e-05	0.000178	CcSEcCtD
Paclitaxel—Fatigue—Etoposide—peripheral nervous system neoplasm	3.24e-05	0.000177	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000177	CcSEcCtD
Paclitaxel—Stomatitis—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000176	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.22e-05	0.000565	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	3.21e-05	0.000564	CbGpPWpGaD
Paclitaxel—Constipation—Etoposide—peripheral nervous system neoplasm	3.21e-05	0.000176	CcSEcCtD
Paclitaxel—Pain—Etoposide—peripheral nervous system neoplasm	3.21e-05	0.000176	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000176	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000176	CcSEcCtD
Paclitaxel—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.2e-05	0.000562	CbGpPWpGaD
Paclitaxel—Dysuria—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000176	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000176	CcSEcCtD
Paclitaxel—BCL2—Direct p53 effectors—TP53—peripheral nervous system neoplasm	3.2e-05	0.000561	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.2e-05	0.000561	CbGpPWpGaD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000174	CcSEcCtD
Paclitaxel—Dizziness—Alitretinoin—peripheral nervous system neoplasm	3.18e-05	0.000174	CcSEcCtD
Paclitaxel—Diarrhoea—Vincristine—peripheral nervous system neoplasm	3.17e-05	0.000174	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000173	CcSEcCtD
Paclitaxel—Haematuria—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000172	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	3.14e-05	0.000551	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	3.14e-05	0.000551	CbGpPWpGaD
Paclitaxel—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000171	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000171	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000171	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000171	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.00017	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.1e-05	0.000544	CbGpPWpGaD
Paclitaxel—Sinusitis—Epirubicin—peripheral nervous system neoplasm	3.1e-05	0.00017	CcSEcCtD
Paclitaxel—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	3.1e-05	0.00017	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000169	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	3.08e-05	0.000541	CbGpPWpGaD
Paclitaxel—Nausea—Dactinomycin—peripheral nervous system neoplasm	3.08e-05	0.000169	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000168	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	3.07e-05	0.000168	CcSEcCtD
Paclitaxel—Dizziness—Vincristine—peripheral nervous system neoplasm	3.07e-05	0.000168	CcSEcCtD
Paclitaxel—Vomiting—Alitretinoin—peripheral nervous system neoplasm	3.06e-05	0.000168	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000167	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000167	CcSEcCtD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.04e-05	0.000534	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.04e-05	0.000533	CbGpPWpGaD
Paclitaxel—Rash—Alitretinoin—peripheral nervous system neoplasm	3.03e-05	0.000166	CcSEcCtD
Paclitaxel—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	3.03e-05	0.000166	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000166	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	3.02e-05	0.00053	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	3.02e-05	0.000166	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000165	CcSEcCtD
Paclitaxel—Headache—Alitretinoin—peripheral nervous system neoplasm	3.01e-05	0.000165	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.01e-05	0.000528	CbGpPWpGaD
Paclitaxel—Renal failure—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000165	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000164	CcSEcCtD
Paclitaxel—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.99e-05	0.000525	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.99e-05	0.000524	CbGpPWpGaD
Paclitaxel—Urticaria—Etoposide—peripheral nervous system neoplasm	2.98e-05	0.000164	CcSEcCtD
Paclitaxel—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000163	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000163	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000163	CcSEcCtD
Paclitaxel—Body temperature increased—Etoposide—peripheral nervous system neoplasm	2.97e-05	0.000163	CcSEcCtD
Paclitaxel—Abdominal pain—Etoposide—peripheral nervous system neoplasm	2.97e-05	0.000163	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000163	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000163	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000162	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.96e-05	0.000519	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	2.96e-05	0.000519	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NCAM1—peripheral nervous system neoplasm	2.95e-05	0.000518	CbGpPWpGaD
Paclitaxel—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000162	CcSEcCtD
Paclitaxel—Vomiting—Vincristine—peripheral nervous system neoplasm	2.95e-05	0.000162	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TP53—peripheral nervous system neoplasm	2.95e-05	0.000517	CbGpPWpGaD
Paclitaxel—Asthenia—Cisplatin—peripheral nervous system neoplasm	2.94e-05	0.000161	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000161	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.00016	CcSEcCtD
Paclitaxel—Rash—Vincristine—peripheral nervous system neoplasm	2.92e-05	0.00016	CcSEcCtD
Paclitaxel—Dermatitis—Vincristine—peripheral nervous system neoplasm	2.92e-05	0.00016	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.00016	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.00016	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.00016	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000159	CcSEcCtD
Paclitaxel—Headache—Vincristine—peripheral nervous system neoplasm	2.91e-05	0.000159	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000158	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000158	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.87e-05	0.000504	CbGpPWpGaD
Paclitaxel—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000157	CcSEcCtD
Paclitaxel—Nausea—Alitretinoin—peripheral nervous system neoplasm	2.86e-05	0.000157	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000156	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	2.85e-05	0.000499	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.82e-05	0.000495	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.81e-05	0.000493	CbGpPWpGaD
Paclitaxel—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	2.81e-05	0.000154	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000154	CcSEcCtD
Paclitaxel—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.79e-05	0.00049	CbGpPWpGaD
Paclitaxel—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000153	CcSEcCtD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.78e-05	0.000488	CbGpPWpGaD
Paclitaxel—Eye disorder—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000152	CcSEcCtD
Paclitaxel—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.77e-05	0.000152	CcSEcCtD
Paclitaxel—ABCC1—Disease—GNS—peripheral nervous system neoplasm	2.77e-05	0.000485	CbGpPWpGaD
Paclitaxel—Tinnitus—Epirubicin—peripheral nervous system neoplasm	2.76e-05	0.000151	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000151	CcSEcCtD
Paclitaxel—Nausea—Vincristine—peripheral nervous system neoplasm	2.75e-05	0.000151	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000151	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000151	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000151	CcSEcCtD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.75e-05	0.000482	CbGpPWpGaD
Paclitaxel—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.00015	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000149	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000149	CcSEcCtD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.72e-05	0.000477	CbGpPWpGaD
Paclitaxel—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000148	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000148	CcSEcCtD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.7e-05	0.000473	CbGpPWpGaD
Paclitaxel—Asthenia—Etoposide—peripheral nervous system neoplasm	2.7e-05	0.000148	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000148	CcSEcCtD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.69e-05	0.000472	CbGpPWpGaD
Paclitaxel—Angiopathy—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000147	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000147	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000147	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.67e-05	0.000469	CbGpPWpGaD
Paclitaxel—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	2.67e-05	0.000146	CcSEcCtD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.66e-05	0.000467	CbGpPWpGaD
Paclitaxel—Chills—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000146	CcSEcCtD
Paclitaxel—Pruritus—Etoposide—peripheral nervous system neoplasm	2.66e-05	0.000146	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000145	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000145	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000143	CcSEcCtD
Paclitaxel—Vomiting—Cisplatin—peripheral nervous system neoplasm	2.61e-05	0.000143	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000142	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000142	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.59e-05	0.000454	CbGpPWpGaD
Paclitaxel—Rash—Cisplatin—peripheral nervous system neoplasm	2.59e-05	0.000142	CcSEcCtD
Paclitaxel—Dermatitis—Cisplatin—peripheral nervous system neoplasm	2.58e-05	0.000142	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000141	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000141	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.58e-05	0.000452	CbGpPWpGaD
Paclitaxel—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.57e-05	0.000141	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.00014	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.00014	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000139	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000139	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000139	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.54e-05	0.000446	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.54e-05	0.000445	CbGpPWpGaD
Paclitaxel—Tension—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000139	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000138	CcSEcCtD
Paclitaxel—TUBB—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	2.51e-05	0.000441	CbGpPWpGaD
Paclitaxel—Nervousness—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000137	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000137	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.49e-05	0.000438	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—AKT1—peripheral nervous system neoplasm	2.49e-05	0.000437	CbGpPWpGaD
Paclitaxel—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000136	CcSEcCtD
Paclitaxel—Dizziness—Etoposide—peripheral nervous system neoplasm	2.48e-05	0.000136	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	2.48e-05	0.000136	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000136	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000135	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000135	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000134	CcSEcCtD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.44e-05	0.000429	CbGpPWpGaD
Paclitaxel—Nausea—Cisplatin—peripheral nervous system neoplasm	2.44e-05	0.000133	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000133	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000133	CcSEcCtD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.42e-05	0.000424	CbGpPWpGaD
Paclitaxel—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000132	CcSEcCtD
Paclitaxel—NR1I2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.4e-05	0.000421	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—peripheral nervous system neoplasm	2.4e-05	0.00042	CbGpPWpGaD
Paclitaxel—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000131	CcSEcCtD
Paclitaxel—Vomiting—Etoposide—peripheral nervous system neoplasm	2.39e-05	0.000131	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000131	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000131	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.000131	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.00013	CcSEcCtD
Paclitaxel—Rash—Etoposide—peripheral nervous system neoplasm	2.37e-05	0.00013	CcSEcCtD
Paclitaxel—Dermatitis—Etoposide—peripheral nervous system neoplasm	2.37e-05	0.00013	CcSEcCtD
Paclitaxel—Headache—Etoposide—peripheral nervous system neoplasm	2.35e-05	0.000129	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000129	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.35e-05	0.000413	CbGpPWpGaD
Paclitaxel—Tension—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000128	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000128	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.33e-05	0.000409	CbGpPWpGaD
Paclitaxel—Malaise—Epirubicin—peripheral nervous system neoplasm	2.33e-05	0.000127	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	2.33e-05	0.000408	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.32e-05	0.000408	CbGpPWpGaD
Paclitaxel—Nervousness—Doxorubicin—peripheral nervous system neoplasm	2.32e-05	0.000127	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000127	CcSEcCtD
Paclitaxel—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	2.32e-05	0.000406	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNB1—peripheral nervous system neoplasm	2.32e-05	0.000406	CbGpPWpGaD
Paclitaxel—Syncope—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000127	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000127	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000127	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.31e-05	0.000405	CbGpPWpGaD
Paclitaxel—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000126	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000125	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	2.27e-05	0.000124	CcSEcCtD
Paclitaxel—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.26e-05	0.000396	CbGpPWpGaD
Paclitaxel—Cough—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000123	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000123	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.24e-05	0.000393	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000393	CbGpPWpGaD
Paclitaxel—Convulsion—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000122	CcSEcCtD
Paclitaxel—Nausea—Etoposide—peripheral nervous system neoplasm	2.23e-05	0.000122	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	2.23e-05	0.000391	CbGpPWpGaD
Paclitaxel—Hypertension—Epirubicin—peripheral nervous system neoplasm	2.23e-05	0.000122	CcSEcCtD
Paclitaxel—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	2.22e-05	0.00039	CbGpPWpGaD
Paclitaxel—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000121	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000121	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.00012	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.00012	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.00012	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.00012	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—peripheral nervous system neoplasm	2.19e-05	0.00012	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.00012	CcSEcCtD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.17e-05	0.000381	CbGpPWpGaD
Paclitaxel—Discomfort—Epirubicin—peripheral nervous system neoplasm	2.17e-05	0.000119	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	0.000118	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—peripheral nervous system neoplasm	2.15e-05	0.000118	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.15e-05	0.000377	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.000377	CbGpPWpGaD
Paclitaxel—Vertigo—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000118	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000117	CcSEcCtD
Paclitaxel—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	2.14e-05	0.000375	CbGpPWpGaD
Paclitaxel—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000117	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.13e-05	0.000374	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.13e-05	0.000373	CbGpPWpGaD
Paclitaxel—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.12e-05	0.000116	CcSEcCtD
Paclitaxel—BCL2—Focal Adhesion—AKT1—peripheral nervous system neoplasm	2.11e-05	0.000371	CbGpPWpGaD
Paclitaxel—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	0.000116	CcSEcCtD
Paclitaxel—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.11e-05	0.00037	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.11e-05	0.000369	CbGpPWpGaD
Paclitaxel—Oedema—Epirubicin—peripheral nervous system neoplasm	2.11e-05	0.000115	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.11e-05	0.000115	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.1e-05	0.000115	CcSEcCtD
Paclitaxel—Infection—Epirubicin—peripheral nervous system neoplasm	2.09e-05	0.000115	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000114	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	2.08e-05	0.000365	CbGpPWpGaD
Paclitaxel—Shock—Epirubicin—peripheral nervous system neoplasm	2.07e-05	0.000114	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000113	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.07e-05	0.000363	CbGpPWpGaD
Paclitaxel—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.07e-05	0.000113	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000113	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.000113	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000113	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.000112	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.04e-05	0.000358	CbGpPWpGaD
Paclitaxel—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.04e-05	0.000112	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.000111	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.000111	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.000111	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	0.000111	CcSEcCtD
Paclitaxel—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.000354	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.02e-05	0.000354	CbGpPWpGaD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	0.000111	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.01e-05	0.00011	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.00011	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	0.000109	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	1.99e-05	0.000348	CbGpPWpGaD
Paclitaxel—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.000108	CcSEcCtD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000345	CbGpPWpGaD
Paclitaxel—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.96e-05	0.000108	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.95e-05	0.000343	CbGpPWpGaD
Paclitaxel—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.000107	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.000107	CcSEcCtD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.94e-05	0.000341	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.94e-05	0.00034	CbGpPWpGaD
Paclitaxel—Infection—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	0.000106	CcSEcCtD
Paclitaxel—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.93e-05	0.000339	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.93e-05	0.000338	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	1.92e-05	0.000105	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000105	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.000105	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.000105	CcSEcCtD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.91e-05	0.000335	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.91e-05	0.000334	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.9e-05	0.000334	CbGpPWpGaD
Paclitaxel—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.9e-05	0.000104	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	0.000104	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.9e-05	0.000333	CbGpPWpGaD
Paclitaxel—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000104	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.89e-05	0.000104	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.000103	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.88e-05	0.00033	CbGpPWpGaD
Paclitaxel—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000103	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.87e-05	0.000103	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	1.87e-05	0.000328	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.86e-05	0.000327	CbGpPWpGaD
Paclitaxel—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	0.000102	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	1.85e-05	0.000102	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.83e-05	0.0001	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	9.97e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.82e-05	9.96e-05	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—peripheral nervous system neoplasm	1.82e-05	9.95e-05	CcSEcCtD
Paclitaxel—Pain—Epirubicin—peripheral nervous system neoplasm	1.8e-05	9.87e-05	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—peripheral nervous system neoplasm	1.8e-05	9.87e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—HGF—peripheral nervous system neoplasm	1.79e-05	0.000314	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.78e-05	9.73e-05	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.00031	CbGpPWpGaD
Paclitaxel—Insomnia—Doxorubicin—peripheral nervous system neoplasm	1.76e-05	9.65e-05	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.75e-05	0.000307	CbGpPWpGaD
Paclitaxel—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.75e-05	9.59e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	9.52e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.74e-05	9.51e-05	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	9.49e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.72e-05	9.43e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	9.4e-05	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.71e-05	0.0003	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MYC—peripheral nervous system neoplasm	1.7e-05	0.000299	CbGpPWpGaD
Paclitaxel—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	9.28e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	9.22e-05	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	9.2e-05	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.000294	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	1.68e-05	0.000294	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.68e-05	0.000294	CbGpPWpGaD
Paclitaxel—Urticaria—Epirubicin—peripheral nervous system neoplasm	1.67e-05	9.17e-05	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	9.13e-05	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	9.13e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.66e-05	9.12e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.66e-05	9.12e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.61e-05	8.8e-05	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000281	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.6e-05	0.000281	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.59e-05	8.73e-05	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.58e-05	0.000277	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.58e-05	0.000277	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	1.58e-05	0.000277	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.55e-05	8.5e-05	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	8.48e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	8.44e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	8.44e-05	CcSEcCtD
Paclitaxel—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.52e-05	0.000267	CbGpPWpGaD
Paclitaxel—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.51e-05	8.28e-05	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.51e-05	0.000264	CbGpPWpGaD
Paclitaxel—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.49e-05	8.16e-05	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.48e-05	0.00026	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000258	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.46e-05	0.000256	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.45e-05	0.000255	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.44e-05	0.000253	CbGpPWpGaD
Paclitaxel—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.44e-05	7.89e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.44e-05	7.86e-05	CcSEcCtD
Paclitaxel—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.42e-05	0.00025	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MYC—peripheral nervous system neoplasm	1.41e-05	0.000248	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.000247	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.4e-05	0.000246	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.4e-05	0.000246	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—peripheral nervous system neoplasm	1.4e-05	0.000245	CbGpPWpGaD
Paclitaxel—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.4e-05	7.66e-05	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.39e-05	7.63e-05	CcSEcCtD
Paclitaxel—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.39e-05	0.000244	CbGpPWpGaD
Paclitaxel—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	7.55e-05	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000238	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.000237	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.35e-05	0.000236	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000236	CbGpPWpGaD
Paclitaxel—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.34e-05	7.34e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	7.3e-05	CcSEcCtD
Paclitaxel—Rash—Epirubicin—peripheral nervous system neoplasm	1.33e-05	7.27e-05	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.33e-05	7.27e-05	CcSEcCtD
Paclitaxel—Headache—Epirubicin—peripheral nervous system neoplasm	1.32e-05	7.23e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000229	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MYC—peripheral nervous system neoplasm	1.29e-05	0.000226	CbGpPWpGaD
Paclitaxel—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	7.06e-05	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000226	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.28e-05	0.000224	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.26e-05	0.000222	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.26e-05	0.000222	CbGpPWpGaD
Paclitaxel—Nausea—Epirubicin—peripheral nervous system neoplasm	1.25e-05	6.85e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	6.79e-05	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000217	CbGpPWpGaD
Paclitaxel—Rash—Doxorubicin—peripheral nervous system neoplasm	1.23e-05	6.73e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.23e-05	6.72e-05	CcSEcCtD
Paclitaxel—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.000215	CbGpPWpGaD
Paclitaxel—Headache—Doxorubicin—peripheral nervous system neoplasm	1.22e-05	6.69e-05	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.21e-05	0.000213	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000213	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000209	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.19e-05	0.000209	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000208	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.18e-05	0.000208	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.17e-05	0.000205	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.16e-05	0.000204	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—peripheral nervous system neoplasm	1.16e-05	0.000203	CbGpPWpGaD
Paclitaxel—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	6.34e-05	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—MYC—peripheral nervous system neoplasm	1.15e-05	0.000203	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000202	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.15e-05	0.000201	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000199	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.13e-05	0.000198	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000196	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.11e-05	0.000196	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.1e-05	0.000193	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.09e-05	0.000192	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.000189	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—peripheral nervous system neoplasm	1.06e-05	0.000186	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.06e-05	0.000185	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000183	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.000181	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—peripheral nervous system neoplasm	1.03e-05	0.000181	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.03e-05	0.000181	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.02e-05	0.000178	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.95e-06	0.000175	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	9.87e-06	0.000173	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.87e-06	0.000173	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—peripheral nervous system neoplasm	9.85e-06	0.000173	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	9.81e-06	0.000172	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	9.72e-06	0.000171	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	9.5e-06	0.000167	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.39e-06	0.000165	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.25e-06	0.000162	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	9.14e-06	0.00016	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	9.1e-06	0.00016	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.06e-06	0.000159	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.97e-06	0.000157	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.93e-06	0.000157	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	8.85e-06	0.000155	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	8.8e-06	0.000154	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.7e-06	0.000153	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.64e-06	0.000152	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	8.01e-06	0.00014	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—peripheral nervous system neoplasm	8.01e-06	0.00014	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	7.94e-06	0.000139	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.86e-06	0.000138	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—peripheral nervous system neoplasm	7.84e-06	0.000138	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	7.79e-06	0.000137	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	7.66e-06	0.000134	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	7.55e-06	0.000132	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.48e-06	0.000131	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.44e-06	0.000131	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.13e-06	0.000125	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.03e-06	0.000123	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.79e-06	0.000119	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.68e-06	0.000117	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.51e-06	0.000114	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.48e-06	0.000114	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.28e-06	0.00011	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.27e-06	0.00011	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.24e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.18e-06	0.000108	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.09e-06	0.000107	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	5.97e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.74e-06	0.000101	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—peripheral nervous system neoplasm	5.74e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.64e-06	9.9e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.63e-06	9.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.38e-06	9.44e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.3e-06	9.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.27e-06	9.25e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—peripheral nervous system neoplasm	5.07e-06	8.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.03e-06	8.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.97e-06	8.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.96e-06	8.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.88e-06	8.56e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	4.54e-06	7.97e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.33e-06	7.6e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—peripheral nervous system neoplasm	4.23e-06	7.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.11e-06	7.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.05e-06	7.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.97e-06	6.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.48e-06	6.1e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	3.47e-06	6.1e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.32e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.32e-06	5.82e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.27e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.27e-06	5.73e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	2.93e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.67e-06	4.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.62e-06	4.59e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-06	4.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.46e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.38e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.16e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-06	3.76e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.55e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.34e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-06	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.09e-06	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.2e-07	1.26e-05	CbGpPWpGaD
